These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31467997)

  • 1. Newborn Screening for X-Linked Adrenoleukodystrophy.
    Moser AB; Jones RO; Hubbard WC; Tortorelli S; Orsini JJ; Caggana M; Vogel BH; Raymond GV
    Int J Neonatal Screen; 2016 Dec; 2(4):. PubMed ID: 31467997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
    Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
    Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
    Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
    Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
    Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
    Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific newborn screening for X-linked adrenoleukodystrophy.
    Albersen M; van der Beek SL; Dijkstra IME; Alders M; Barendsen RW; Bliek J; Boelen A; Ebberink MS; Ferdinandusse S; Goorden SMI; Heijboer AC; Jansen M; Jaspers YRJ; Metgod I; Salomons GS; Vaz FM; Verschoof-Puite RK; Visser WF; Dekkers E; Engelen M; Kemp S
    J Inherit Metab Dis; 2023 Jan; 46(1):116-128. PubMed ID: 36256460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.
    Lee S; Clinard K; Young SP; Rehder CW; Fan Z; Calikoglu AS; Bali DS; Bailey DB; Gehtland LM; Millington DS; Patel HS; Beckloff SE; Zimmerman SJ; Powell CM; Taylor JL
    JAMA Netw Open; 2020 Jan; 3(1):e1920356. PubMed ID: 32003821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.
    Chen HA; Hsu RH; Chen PW; Lee NC; Chiu PC; Hwu WL; Chien YH
    Mol Genet Metab Rep; 2022 Sep; 32():100902. PubMed ID: 36046390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines.
    Vogel BH; Bradley SE; Adams DJ; D'Aco K; Erbe RW; Fong C; Iglesias A; Kronn D; Levy P; Morrissey M; Orsini J; Parton P; Pellegrino J; Saavedra-Matiz CA; Shur N; Wasserstein M; Raymond GV; Caggana M
    Mol Genet Metab; 2015 Apr; 114(4):599-603. PubMed ID: 25724074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring.
    Bonaventura E; Alberti L; Lucchi S; Cappelletti L; Fazzone S; Cattaneo E; Bellini M; Izzo G; Parazzini C; Bosetti A; Di Profio E; Fiore G; Ferrario M; Mameli C; Sangiorgio A; Masnada S; Zuccotti GV; Veggiotti P; Spaccini L; Iascone M; Verduci E; Cereda C; Tonduti D;
    Front Neurol; 2022; 13():1072256. PubMed ID: 36698902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy.
    Wiens K; Berry SA; Choi H; Gaviglio A; Gupta A; Hietala A; Kenney-Jung D; Lund T; Miller W; Pierpont EI; Raymond G; Winslow H; Zierhut HA; Orchard PJ
    Am J Med Genet A; 2019 Jul; 179(7):1205-1213. PubMed ID: 31074578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoleukodystrophy in the era of newborn screening.
    Eng L; Regelmann MO
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):47-55. PubMed ID: 31789721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.
    Sandlers Y; Moser AB; Hubbard WC; Kratz LE; Jones RO; Raymond GV
    Mol Genet Metab; 2012 Mar; 105(3):416-20. PubMed ID: 22197596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.
    Theda C; Gibbons K; Defor TE; Donohue PK; Golden WC; Kline AD; Gulamali-Majid F; Panny SR; Hubbard WC; Jones RO; Liu AK; Moser AB; Raymond GV
    Mol Genet Metab; 2014 Jan; 111(1):55-7. PubMed ID: 24268529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor.
    Barendsen RW; Dijkstra IME; Visser WF; Alders M; Bliek J; Boelen A; Bouva MJ; van der Crabben SN; Elsinghorst E; van Gorp AGM; Heijboer AC; Jansen M; Jaspers YRJ; van Lenthe H; Metgod I; Mooij CF; van der Sluijs EHC; van Trotsenburg ASP; Verschoof-Puite RK; Vaz FM; Waterham HR; Wijburg FA; Engelen M; Dekkers E; Kemp S
    Front Cell Dev Biol; 2020; 8():499. PubMed ID: 32626714
    [TBL] [